Targeted next generation sequencing panel based screening and diagnosis of bone marrow failure cohort reveals diverse genomic landscape of pathogenic germline variants-Reference-Cited by-同舟云学术

Targeted next generation sequencing panel based screening and diagnosis of bone marrow failure cohort reveals diverse genomic landscape of pathogenic germline variants

Published:2022-11-07 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

BHATIA PRATEEK¹,Palla Swetha²,Senguttuvan Gnanamani²,Chhabra Prashant³,Singh Minu²,Khadwal Alka²,Jain Arihant²,Sharma Pankaj²,Thakur Rozy²,Sreedharanu Sreejesh²,Bansal Deepak²,Jain Richa²,Peyam Srinivasan²,Mohapatra Sonali⁴,Jindal Ankur²,Suri Deepti²,Das Reena²,Varma Neelam²,Malhotra Pankaj²,Trehan Amita²

Affiliation:

1. PGIMER

2. PGIMER Chandigarh

3. AIIMS Bathinda

4. AIIMS Bhubaneshwar

Abstract

Abstract Introduction: Current study is a 4 year experience in diagnosis and screening of bone marrow failure cases using a targeted sequencing panel. Methods: A total of 171 cases underwent targeted NGS and were categorized as suspected inherited bone marrow failure syndrome (IBMFS) group (106/62%) and idiopathic aplastic anemia (IAA) group (65/38%) based on clinical and laboratory criteria. Results: 110 (64%) were pediatric (0-12 years) and 61 (36%) adolescent and adults (13-47 years). In suspected IBMFS group, 47 (44%) were positive for a pathogenic variation while in IAA group, 8 (12%) revealed a silent germline pathogenic variation. Whole exome sequencing performed in 15/61 suspected IBMFS group cases, revealed a clinically important variation in 3 (20%) cases. The targeted panel helped in establishing a diagnosis in 44% (27/61) of phenotypically heterogenous unclassified bone marrow failure syndrome cases and also led to amendment of clinical diagnosis in 5 (4.7%) of genotyped cases. Conclusion: Overall targeted NGS panel yield was comparable to western data, however, this was achievable at 1/5th the cost, making it a cost-effective panel for resource constraint settings.

Publisher

Research Square Platform LLC

Reference24 articles.

1. DavidGNathan,StuartHOrkin.Nathan and Oski’s Hematology and oncology of infants and childhood Ch. 7 (Elsevier Saunders,2015).

2. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome;Gluckman E,2008

3. Pediatric bone marrow failure: Clinical, hematological and targeted next generation sequencing data;Chhabra P,2021

4. Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes;Ghemlas I,2015

5. Clinical utility of next-generation sequencing for inherited bone marrow failure syndromes;Muramatsu H,2017